Fig. 2.
(A) Expression of human CD45 antigen on BMC collected from NOD/SCID mice untransplanted (a) and transplanted with inoculated 1 × 106 CB MNC (b) and those cocltured with AGM-S3 for 4 weeks (c). (B) Specific subsets of human hematopoietic cells in BMC of the NOD/SCID mouse transplanted with cocultured human CB MNC quantified by gating on human CD45-PECy5-positive cells and then assessing staining with antihuman CD13- PE, CD33-PE, CD14-PE, CD19-PE, and CD34-FITC. BMC of the recipient mouse were collected 5 weeks after transplantation.
